Effects of troglitazone on the growth and differentiation of hematopoietic cell lines

International Journal of Oncology

Volumn 13, Issue 6, 1998, Pages 1263-1267

  Fujimura, Satoshi ^a,c   Suzumiya, Junji ^a   Nakamura, Kiyoko ^b   Ono, Junko ^a,b  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

Differentiation; Growth arrest; Hemotopoietic cells; HL 60; Thiazolidinedione; Troglitazone

Indexed keywords

CELL NUCLEUS RECEPTOR; THIAZOLIDINE DERIVATIVE; TROGLITAZONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; ELECTRON MICROSCOPY; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031771993     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.6.1263     Document Type: Article

References (20)

1. Saltiel AR and Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45: 1661-1669, 1996.
2. Ohsumi J, Sakakibara S, Yamaguchi J, Miyadai K, Yoshioka S, Fujiwara T, Horikoshi H and Serizawa N: Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology 135: 2279-2282, 1994.
3. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM and Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 270: 12953-12956, 1995.
4. 2 is a ligand for the adipocytc determiation factor PPARγ. Cell 83: 803-812, 1995.
5. Braissant O, Foufelle F, Scotto C, Dauça M and Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -ß, and -γ in the adult rat. Endocrinology 137: 354-366, 1996.
6. Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K, Hsieh L, Green G and Nimer SD: Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 4: 281-299, 1995.
7. Tontonoz P, Nagy L, Alvarez JGA, Thomazy VA and Evans RM: PPARy promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252, 1998.
8. Yamada Y, Sugawara K, Hata T, Tsuruta K, Moriuchi R, Maeda T, Atogami S, Murata K, Fujimoto K, Kohno T, Tsukasaki K, Tomonaga M, Hirakata Y and Kamihira S: Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2 dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor α on ATL cells. Blood 91: 4265-4272, 1998.
9. Fujimura S, Suzumiya J, Anzai K, Ohkubo K, Hata T, Yamada Y, Kamihira S, Kikuchi M and Ono J: Retinoic acids induce growth inhibiton and apoptosis in adult T-cell leukemia (ATL) cell lines. Leuk Res 22: 611-618, 1998.
10. Collins SJ: The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70: 1233-1244, 1987.
11. Benito A, Grillot D, Nuñez G and Fernández-Luna JL: Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocytic cells. Am J Pathol 146: 481-490, 1995.
12. Law RE, Meehan WP, Xi X-P, Graf K, Wuthrich DA, Coats W, Faxon D and Hsueh WA: Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J Clin Invest 98: 1897-1905, 1996.
13. Graf K, Xi X-P, Hsueh WA and Law RE: Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells. FEBS Lett 400: 119-121, 1997.
14. Kihara S, Ouchi N, Funahashi T, Shinohara E, Tamura R, Yamashita S and Matsuzawa Y: Troglitazone enhances glucose uptake and inhibits mitogen-activated protein kinase in human aortic smooth muscle cells. Atherosclerosis 136: 163-168, 1998.
15. Altiok S, Xu M and Spiegelman BM: PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Gene Dev 11: 1987-1998, 1997.
16. Nakamaki T, Kawamata N, Schwaller J, Tobler A, Fey M, Pakkala S, Lee YY, Kim BK, Fukuchi K, Tsuruoka N, Kahan J, Miller CW and Koeffler HP: Structual integrity of the cyclin-dependent kinase inhibitor genes, p 15, p16 and p18 in myeloid leukaemias. Br J Haematol 91: 139-149, 1995.
17. Steinman RA, Huffman B, Iro A, Guillouf C, Liebermann DA and El-Houseini ME: Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396, 1994.
18. Jiang H, Lin J, Su Z-z, Collart FR, Huberman E and Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406, 1994.
19. WAF1/CIP1 expression by p53-independent pathways. Oncogene 12: 1557-1564, 1996.
20. Valledor AF, Borràs, FE, Cullell-Young M and Celada A: Transcription factors that regulate monocyte/macrophage differentiation. J Leukoc Biol 63: 405-417, 1998.